The company holds a Beta of 0.0, which implies not very significant fluctuations relative to the market. the returns on MARKET and Organo are completely uncorrelated.
Risk-Adjusted Performance
Weakest
Weak
Strong
Over the last 90 days Organo has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable forward-looking indicators, Organo is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
Quick Ratio
2.13
Fifty Two Week Low
75.25
Payout Ratio
9.40%
Fifty Two Week High
75.25
Organo
Organo Relative Risk vs. Return Landscape
If you would invest (100.00) in Organo on October 29, 2025 and sell it today you would earn a total of 100.00 from holding Organo or generate -100.0% return on investment over 90 days. Organo is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded pink sheets are less volatile than Organo, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days.
Expected Return
Risk
Organo Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Organo for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Organo can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Organo is not yet fully synchronised with the market data
Organo has some characteristics of a very speculative penny stock
Organo has a very high chance of going through financial distress in the upcoming years
About 43.0% of the company outstanding shares are owned by corporate insiders
Organo Fundamentals Growth
Organo Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Organo, and Organo fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Organo Pink Sheet performance.
Things to note about Organo performance evaluation
Checking the ongoing alerts about Organo for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Organo help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Organo is not yet fully synchronised with the market data
Organo has some characteristics of a very speculative penny stock
Organo has a very high chance of going through financial distress in the upcoming years
About 43.0% of the company outstanding shares are owned by corporate insiders
Evaluating Organo's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Organo's pink sheet performance include:
Analyzing Organo's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Organo's stock is overvalued or undervalued compared to its peers.
Examining Organo's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
Evaluating Organo's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Organo's management team can help you assess the Company's leadership.
Pay attention to analyst opinions and ratings of Organo's pink sheet. These opinions can provide insight into Organo's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Organo's pink sheet performance is not an exact science, and many factors can impact Organo's pink sheet market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Consideration for investing in Organo Pink Sheet
If you are still planning to invest in Organo check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Organo's history and understand the potential risks before investing.